NeuroPace Investor Relations Material
Latest events
Q2 2025
NeuroPace
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from NeuroPace Inc
Access all reports
NeuroPace Inc designs and manufactures neurostimulation systems for the treatment of neurological disorders such as epilepsy. The company’s responsive neurostimulation technology monitors brain activity and delivers targeted stimulation to prevent seizures. It serves the medical device and neurology markets. The company is headquartered in Mountain View, California, and its shares are listed on the NASDAQ.
Key slides for NeuroPace Inc
Investor Presentation
NeuroPace Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
NeuroPace Inc
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
NPCE
Country
🇺🇸 United States